Dr. Richard K. Parrish II, MD

Dr. Parrish practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Parrish's NPI, 1881619880, was assigned on July 12, 2006. Dr. Parrish graduated from Indiana University School Of Medicine in 1976. Dr. Parrish holds Florida license ME40377.

Dr. Parrish's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Parrish's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Parrish to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parrish practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Parrish's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Parrish is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Parrish's licenses on file in 4 states: Florida, New Jersey, Indiana and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Parrish treats.

CMS data shows 1,493 Medicare services from Dr. Parrish across 7 procedure codes in 2024, for 535 Medicare patients. Medicare paid $55,375 for them.

CMS counts 535 Medicare patients who saw Dr. Parrish in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Parrish's median patient age at 77, with 54% women.

In 2024, Dr. Parrish wrote 3,653 Medicare Part D claims for 607 patients. 68% of them were for generic drugs. CMS names the drug for 3,567 of them, across 25 drugs with 11 or more claims each, at $233,913 in total drug cost. In 2023, CMS named 4,209 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Parrish for performance year 2024, reported as part of a group. Dr. Parrish accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 124 papers to Dr. Parrish, published from 2006 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Intraocular Pressure, Glaucoma and Glaucoma, Open-Angle. Dr. Parrish has published most often in Am J Ophthalmol. Dr. Parrish's most frequent co-authors are Donald Lyle Budenz, MD, Steven J. Gedde, MD and Ta Chen Peter Chang, MD.

Dmand AI links Dr. Parrish to 2 clinical trials. Conditions studied include Glaucoma and Ocular Hypertension. University of Miami sponsors the most, 2.

CMS Open Payments shows 16 general payments to Dr. Parrish from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 42% of the total. Alimera Sciences, Inc. paid the most, $5,827.

Dmand AI lists 3 awards for Dr. Parrish, most recently Super Doc in 2014.

Dr. Parrish graduated from Indiana University School Of Medicine in 1976. Dr. Parrish is a member of AAO.

Dr. Parrish is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.